Recherche en direct
TopFind récupère les correspondances les plus récentes pour votre recherche.
Nous avons examiné 6 résultats en direct pour herzuma et retenu les 3 options qui semblent les plus utiles à comparer en premier.
Les thèmes les plus forts dans cette sélection sont Oncology et Biosimilar.
Source: Celltrion Healthcare Philippines Inc.
Description
Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics.
Idéal pour
HER2 Positive cancer, Oncology therapy et Biosimilar oncology
Évaluation
Source: Celltrion Healthcare Singapore Private Limited
Description
Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies.
Idéal pour
HER2 Positive cancer care, Breast cancer patients et Affordable trastuzumab access
Évaluation
Source: Celltrion Healthcare
Description
Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials.
Idéal pour
HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy et Oncology infusion treatment
Évaluation
| Comparer | Herzuma (Trastuzumab) | Herzuma | Herzuma (Trastuzumab) |
|---|---|---|---|
| Source | Celltrion Healthcare Philippines Inc. | Celltrion Healthcare Singapore Private Limited | Celltrion Healthcare |
| Description | Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics. | Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies. | Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials. |
| Idéal pour | HER2 Positive cancer, Oncology therapy et Biosimilar oncology | HER2 Positive cancer care, Breast cancer patients et Affordable trastuzumab access | HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy et Oncology infusion treatment |
| Action | |||
| Évaluation |
Si vous voulez commencer par l'option la plus équilibrée, je vous recommande :
"Herzuma (Trastuzumab) de Celltrion Healthcare Philippines Inc.."
Je l'ai choisi parce que Herzuma offers a clinically validated biosimilar option for patients with HER2-positive oncological conditions.